Skip to main content
SpringerLink
Log in

Sentinel Navigation Surgery for Local Advanced Cervical Cancer

  • Chapter
  • First Online:
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer

Part of the book series: Comprehensive Gynecology and Obstetrics ((CGO))

  • 66 Accesses

Abstract

Cervical cancer is the fourth most frequent cancer in women and the fourth leading cause of cancer related deaths in females. Primary surgical treatment, including radical hysterectomy and pelvic lymph node dissection (PLND), is considered the standard of care. However, lymphedema has been observed in 35% of patients who undergo surgery, including lymphadenectomy for cervical cancer. The sentinel lymph nodes (SLN) are the first lymph nodes to receive drainage from their tumor. An SLN biopsy for patients with cervical cancer was first reported in 1995. SLN biopsy appears to be feasible for detecting lymph node metastasis in patients with early-stage cervical cancer. The SLN biopsy can reduce surgical morbidities such as intraoperative blood loss and lower the risk of postoperative complications of lymphedema and lymphocyst for the patients with radical hysterectomy of cervical cancer. Recently, several reports have shown that indocyanine green (ICG) has a feasible detection rate in patients with uterine cervical cancer. Several studies suggest that SLN biopsy without a systematic lymphadenectomy is a safe treatment modality for early-stage cervical cancer and a tumor size ≤2 cm, and there was no significant difference between SLN biopsy and lymphadenectomy in the oncologic outcomes for the patients with cervical cancer. However, SLN biopsy and/or SLN mapping for the patients with cervical cancer has not been yet covered by public health insurance at the present time in Japan, and only 22% facilities have experience in SLN biopsy for gynecological cancers in Japan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  2. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000;10(4):305–12.

    Article  PubMed  Google Scholar 

  3. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol. 2007;12(3):165–75.

    Article  PubMed  Google Scholar 

  4. Kim SI, et al. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection. Eur J Obstet Gynecol Reprod Biol. 2015;192:31–6.

    Article  PubMed  Google Scholar 

  5. Carlson JW, et al. GOG 244-the lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients. Gynecol Oncol. 2020;156(2):467–74.

    Article  PubMed  Google Scholar 

  6. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456–66.

    Article  CAS  PubMed  Google Scholar 

  7. Lyman GH, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.

    Article  PubMed  Google Scholar 

  8. Morton DL, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307–17.

    Article  CAS  PubMed  Google Scholar 

  9. Van der Zee AG, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884–9.

    Article  PubMed  Google Scholar 

  10. Echt ML, et al. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J. 1999;92(2):204–8.

    Article  CAS  PubMed  Google Scholar 

  11. Koh WJ, et al. Cervical cancer, version 2.2015. J Natl Compr Cancer Netw. 2015;13(4):395–404; quiz 404.

    Article  CAS  Google Scholar 

  12. Togami S, et al. Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study. Int J Clin Oncol. 2021;26(5):971–9.

    Article  CAS  PubMed  Google Scholar 

  13. Beavis AL, et al. Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer. Gynecol Oncol. 2016;143(2):302–6.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Buda A, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer (99m)Tc and/or blue dye. Ann Surg Oncol. 2016;23(7):2183–91.

    Article  PubMed  Google Scholar 

  15. Martínez-Palones JM, et al. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol. 2004;92(3):845–50.

    Article  PubMed  Google Scholar 

  16. Wang L, et al. Sentinel lymph node mapping in early-stage cervical cancer: meta-analysis. Medicine (Baltimore). 2021;100(34):e27035.

    Article  CAS  PubMed  Google Scholar 

  17. Persson J, et al. Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer. Gynecol Oncol. 2017;147(1):120–5.

    Article  PubMed  Google Scholar 

  18. Benedetti-Panici P, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer. 2000;88(10):2267–74.

    Article  CAS  PubMed  Google Scholar 

  19. Girardi F, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34(2):206–11.

    Article  CAS  PubMed  Google Scholar 

  20. Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol. 2012;124(1):78–82.

    Article  PubMed  Google Scholar 

  21. Lührs O, et al. Combining indocyanine green and Tc(99)-nanocolloid does not increase the detection rate of sentinel lymph nodes in early stage cervical cancer compared to indocyanine green alone. Gynecol Oncol. 2020;156(2):335–40.

    Article  PubMed  Google Scholar 

  22. Frumovitz M, et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018;19(10):1394–403.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kadkhodayan S, et al. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur J Surg Oncol. 2015;41(1):1–20.

    Article  CAS  PubMed  Google Scholar 

  24. Wang XJ, Fang F, Li YF. Sentinel-lymph-node procedures in early stage cervical cancer: a systematic review and meta-analysis. Med Oncol. 2015;32(1):385.

    Article  PubMed  Google Scholar 

  25. Wu Y, et al. Sentinel lymph node biopsy in cervical cancer: a meta-analysis. Mol Clin Oncol. 2013;1(6):1025–30.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tanaka T, et al. The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye. J Gynecol Oncol. 2017;28(2):e13.

    Article  PubMed  Google Scholar 

  27. Geppert B, et al. A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol. 2017;145(2):256–61.

    Article  PubMed  Google Scholar 

  28. Bollino M, et al. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy. Int J Gynecol Cancer. 2020;30(3):339–45.

    Article  PubMed  Google Scholar 

  29. Bonneau C, et al. Lymphatic and nerve distribution throughout the parametrium. Gynecol Oncol. 2013;131(3):708–13.

    Article  CAS  PubMed  Google Scholar 

  30. Lührs O, et al. Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy. Gynecol Oncol. 2022;165(3):466–71.

    Article  PubMed  Google Scholar 

  31. Ouldamer L, et al. Unusual localizations of sentinel lymph nodes in early stage cervical cancer: a review. Surg Oncol. 2012;21(3):e153–7.

    Article  PubMed  Google Scholar 

  32. Balaya V, et al. Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer. Gynecol Oncol. 2019;154(1):102–9.

    Article  CAS  PubMed  Google Scholar 

  33. Balaya V, et al. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer. Gynecol Oncol. 2020;156(1):93–9.

    Article  CAS  PubMed  Google Scholar 

  34. Kim JH, et al. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer. World J Surg Oncol. 2018;16(1):52.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Leijte JA, et al. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med. 2009;50(3):364–7.

    Article  PubMed  Google Scholar 

  36. Salvo G, et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017;145(1):96–101.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Abu-Rustum NR, Khoury-Collado F, Gemignani ML. Techniques of sentinel lymph node identification for early-stage cervical and uterine cancer. Gynecol Oncol. 2008;111(2 Suppl):S44–50.

    Article  PubMed  Google Scholar 

  38. Eiriksson LR, Covens A. Sentinel lymph node mapping in cervical cancer: the future? BJOG. 2012;119(2):129–33.

    Article  CAS  PubMed  Google Scholar 

  39. Favre G, et al. Sentinel lymph-node biopsy in early-stage cervical cancer: the 4-year follow-up results of the senticol 2 trial. Front Oncol. 2020;10:621518.

    Article  PubMed  Google Scholar 

  40. Devaja O, et al. Sentinel lymph node biopsy alone in the management of early cervical carcinoma. Int J Gynecol Cancer. 2022;32(1):15–20.

    Article  PubMed  Google Scholar 

  41. Lennox GK, Covens A. Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer? Gynecol Oncol. 2017;144(1):16–20.

    Article  PubMed  Google Scholar 

  42. Niikura H, et al. Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer. Int J Gynecol Cancer. 2012;22(7):1244–50.

    Article  PubMed  Google Scholar 

  43. Yahata H, et al. Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer. Gynecol Oncol. 2022;165(1):149–54.

    Article  PubMed  Google Scholar 

  44. Cibula D, et al. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX). Int J Gynecol Cancer. 2019;29(1):212–5.

    Article  PubMed  Google Scholar 

  45. Tu H, et al. Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010). Int J Gynecol Cancer. 2020;30(11):1829–33.

    Article  PubMed  Google Scholar 

  46. Lecuru FR, et al. SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study. Int J Gynecol Cancer. 2019;29(4):829–34.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Mathevet P, et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer. 2021;148:307–15.

    Article  PubMed  Google Scholar 

  48. Yahata H, et al. Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer. Int J Clin Oncol. 2018;23(6):1167–72.

    Article  PubMed  Google Scholar 

  49. Devaja O, et al. A prospective single-center study of sentinel lymph node detection in cervical carcinoma: is there a place in clinical practice? Int J Gynecol Cancer. 2012;22(6):1044–9.

    Article  PubMed  Google Scholar 

  50. Bats AS, et al. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol. 2013;20(2):413–22.

    Article  PubMed  Google Scholar 

  51. Wuntakal R, et al. Location of sentinel lymph node in cervical carcinoma and factors associated with unilateral detection. Int J Gynecol Cancer. 2015;25(9):1663–8.

    Article  PubMed  Google Scholar 

  52. Nica A, et al. Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer? Int J Gynecol Cancer. 2020;30(3):285–90.

    Article  PubMed  Google Scholar 

  53. Guani B, et al. The clinical impact of low-volume lymph nodal metastases in early-stage cervical cancer: the senticol 1 and senticol 2 trials. Cancers (Basel). 2020;12(5):1061.

    Article  PubMed  Google Scholar 

  54. Notomi T, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Tsujimoto M, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007;13(16):4807–16.

    Article  CAS  PubMed  Google Scholar 

  56. Creasman WT, et al. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;60(8 Suppl):2035–41.

    Article  CAS  PubMed  Google Scholar 

  57. Kumagai K, et al. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer. 2014;17(2):273–80.

    Article  CAS  PubMed  Google Scholar 

  58. Medas F, et al. Evaluation of accuracy of one-step nucleic acid amplification (OSNA) in diagnosis of lymph node metastases of papillary thyroid carcinoma. Diagnostic study. Ann Med Surg (Lond). 2019;46:17–22.

    Article  PubMed  Google Scholar 

  59. Shi F, et al. One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis. Br J Cancer. 2017;117(8):1185–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Togami S, et al. Evaluation of the one-step nucleic acid amplification assay for detecting lymph node metastasis in patients with cervical and endometrial cancer: a multicenter prospective study. Gynecol Oncol. 2023;170:70–6.

    Article  CAS  PubMed  Google Scholar 

  61. Fanfani F, et al. One-step nucleic acid amplification (OSNA): a fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer. PLoS One. 2018;13(4):e0195877.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kosťun J, et al. One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients. J Surg Oncol. 2019;119(3):361–9.

    Article  PubMed  Google Scholar 

  63. López-Ruiz ME, et al. One-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastasis in endometrial cancer. Gynecol Oncol. 2016;143(1):54–9.

    Article  PubMed  Google Scholar 

  64. Manzour N, et al. Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis. Gynecol Oncol. 2022;164(2):455–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan

    Yoshito Terai

Authors
  1. Yoshito Terai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshito Terai .

Editor information

Editors and Affiliations

  1. Akasaka Sanno Medical Center, International University of Health and Welfare Graduate School, Tokyo, Japan

    Daisuke Aoki

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Terai, Y. (2024). Sentinel Navigation Surgery for Local Advanced Cervical Cancer. In: Aoki, D. (eds) Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer. Comprehensive Gynecology and Obstetrics. Springer, Singapore. https://doi.org/10.1007/978-981-99-9396-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-9396-3_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-9395-6

  • Online ISBN: 978-981-99-9396-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation